Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Ravenquest Biomed Inc RVVQF

Ravenquest BioMed Inc is a Canada-based diversified cannabis company with divisions focused upon cannabis production, management services and consulting and specialized research and development. It provides integrated solutions to companies in the cannabis industry and provides growing and drying technologies, patient and genetic management systems, and security management solutions The company operates through the following segments - Consulting business and Cultivation and Sale of Medical Cannabis.


GREY:RVVQF - Post by User

Post by ourrugon Oct 23, 2019 9:38pm
262 Views
Post# 30262118

4 Takeaways From the Midas Letter Interview

4 Takeaways From the Midas Letter Interview
On the consulting side: first-of-its-kind! We (RavenQuest) have now created a pathway back from suspension to full license. This creates a probability story that if they (CannTrust) follow the right process they can also get their license back. 
 
On the Bonify side: we were able to maintain our cultivation license, so we would be able to fill the vault up completely with dried flower product. So now with that allows us to do to get instantaneously back into revenue.
 
On the newly established edibles market: announced a joint venture with not-so-gentle Tea to create the tea product which I think is one of the most reasonable ways to bring certain demographics into it. We are going to be testing our Vape product there (McGill Cannabis Center for Excellence consisting of six faculties of 92 researchers) to make sure there’s no harm. Take that study to Health Canada along with our product actually get our Vape Pen license. 
 
On the RavenQuest revenue side: the Bonify news really just tells the world that not only are we a technology company that grows cannabis, we’re also a consulting company that can help people when things get into trouble or they need some help in that area. 
 
See Midas Letter interview here: https://youtu.be/O-8wCCohyRs
 
<< Previous
Bullboard Posts
Next >>